Genetic polymorphisms of xenobiotic detoxification system in the populations of Russians and Buryats
https://doi.org/10.25557/2073-7998.2023.04.17-31
Abstract
Background. Gene polymorphism of the xenobiotic detoxification system is associated with drug resistance and human diseases such as cancer, Parkinson’s disease, Alzheimer’s disease, atherosclerosis, liver cirrhosis, aging, cataract formation, infertility, insomnia. Frequency of the polymorphic variants of GSTs genes varies in different world populations.
The purpose of this study is to characterize the frequency distribution of genotypes of the GSTM1, GSTT1 genes, as well as genotypes and alleles of the Ile105Val, Ala114Val polymorphic variants of the GSTP1 gene in the populations of the Russians and the Buryats living in Eastern Siberia and to establish the ethnic differences in the frequency characteristics of the studied genes.
Methods. The sample included 461 people, including 264 Russians and 197 Buryats. Molecular genetic study of deletion polymorphism of GSTT1 and GSTM1 genes was carried out using the polymerase chain reaction (PCR) method with electrophoretic detection. The Ile105Val (rs1695) and Ala114Val (rs1138272) polymorphism of the GSTP1 gene was studied using the real-time polymerase chain reaction (Real-Time PCR) method.
Results. Comparative analysis of the frequency distribution of genotypes of the GSTM1 and GSTT1 genes did not reveal statistically significant differences between the compared population samples. The frequency of the deletion genotype of the GSTM1 gene in the populations of Russians and Buryats was 44.7 and 48.7%, of the GSTT1 gene 22.4 and 30.5%, respectively. It was shown that there are statistically significant differences in the frequency distribution of genotypes of polymorphic variants Ile105Val (p=0.023) and Ala114Val (p=0.007) of the GSTP1 gene between the compared population samples. The frequency of the rare alleles in the populations of Russians and Buryats was as follows: allele G (Ile 105Val) - 23.67 and 20.56%, allele T (Ala 114 Val) - 10.23 and 4.57% (p=0.002), respectively.
Conclusions. The compared population samples of the Russians and the Buryats do not differ in the frequency of deletion genotypes of the GSTM1, GSTT1 genes. At the same time, significant differences in the frequency distribution of genotypes of the Ile105Val, Ala114Val polymorphic variants of the GSTP1 gene are observed in the compared groups. Comparison of the data obtained in this study with similar data in other world populations showed that the frequency characteristics of GSTs genes in the studied populations of the Russians and the Buryats are within the frequency of these genes in other European and Asian populations.
About the Authors
E. V. BelyaevaRussian Federation
16, Timiryazev st., Irkutsk, 664003
T. A. Bairova
Russian Federation
16, Timiryazev st., Irkutsk, 664003
O. A. Ershova
Russian Federation
16, Timiryazev st., Irkutsk, 664003
A. Yu. Sambyalova
Russian Federation
16, Timiryazev st., Irkutsk, 664003
A. I. Paramonov
Russian Federation
16, Timiryazev st., Irkutsk, 664003
N. A. Kurashova
Russian Federation
16, Timiryazev st., Irkutsk, 664003
B. G. Dashiyev
Russian Federation
16, Timiryazev st., Irkutsk, 664003
S. I. Kolesnikov
Russian Federation
16, Timiryazev st., Irkutsk, 664003
L. I. Kolesnikova
Russian Federation
16, Timiryazev st., Irkutsk, 664003
References
1. Cunha V., Rodrigues P., Santos M.M., et al. Danio rerio embryos on Prozac - Effects on the detoxification mechanism and embryo development. Aquat Toxicol. 2016;178:182-189. doi: 10.1016/j.aquatox.2016.08.003
2. Chernyak Yu.I., Kolesnikov S.I., Chernyak E.V. Tsitokhrom P450: Osnovnyye predstavleniya, metody issledovaniya, znacheniye dlya prakticheskoy meditsiny (2-ye izdaniye, ispravlennoye) [Cytochrome P450: Basic concepts, research methods, implications for practical medicine (2nd edition, revised)]. Irkutsk: Izd-vo IGU[ Irkutsk: IGU Publishing House], 2014. 47 p. (In Russ.)
3. Chernyak Yu.I., Grassman J.A., Kolesnikov S.I. Vliyaniye stoykikh organicheskikh zagryazniteley na biotransformatsiyu ksenobiotikov [Influence of persistent organic pollutants on biotransformation of xenobiotics]. Novosibirsk: Nauka, 2007. 134 p. (In Russ.)
4. Whalen R., Boyer T.D. Human glutathione S-transferases. Semin Liver Dis. 1998;18(4):345-358. doi:10.1055/s-2007-1007169
5. Sheweita S.A., Tilmisany A.K. Cancer and phase II drug-metabolizing enzymes. Curr Drug Metab. 2003;4(1):45-58. doi:10.2174/1389200033336919
6. Glesse N., Rohr P., Monticielo O.A., et al. Genetic polymorphisms of glutathione S-transferases and cytochrome P450 enzymes as susceptibility factors to systemic lupus erythematosus in southern Brazilian patients. Mol Biol Rep. 2014;41(9):6167-6179. doi:10.1007/s11033-014-3496-8
7. Finotti A.C., Costa E., Silva R.C. et al. Glutathione S-transferase M1 and T1 polymorphism in men with idiopathic infertility. Genet Mol Res. 2009;8(3):1093-1098. Published 2009 Sep 8. doi:10.4238/vol8-3gmr642
8. Prysyazhnyuk V., Sydorchuk L., Sydorchuk R., et al. Glutathione-S-transferases genes-promising predictors of hepatic dysfunction. World J Hepatol. 2021;13(6):620-633. doi:10.4254/wjh.v13.i6.620
9. Tin A., Scharpf R., Estrella M.M., et al. The Loss of GSTM1 Associates with Kidney Failure and Heart Failure. J Am Soc Nephrol. 2017;28(11):3345-3352. doi:10.1681/ASN.2017030228
10. Fontana X., Peyrotte I., Valente E., et al. Glutathion S-transférase mu 1 (GSTM1): gène de susceptibilité du cancer du sein [Glutathione S-transferase mu 1 (GSTM1): susceptibility gene of breast cancer]. Bull Cancer. 1997;84(1):35-40.
11. Garte S., Gaspari .L, Alexandrie A.K., et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2001;10(12):1239-1248.
12. Cunha V, Rodrigues P, Santos MM, et al. Danio rerio embryos on Prozac - Effects on the detoxification mechanism and embryo development. Aquat Toxicol. 2016;178:182-189. doi:10.1016/j.aquatox.2016.08.003
13. Diedrich A., Bock H.C., König F., et al. Expression of glutathione S-transferase T1 (GSTT1) in human brain tumours. Histol Histopathol. 2006;21(11):1199-1207. doi:10.14670/HH-21.1199
14. Naito M., Goto Y., Ishida Y., et al. Alternative genotyping method of GSTT1 null/present polymorphism. Expert Rev Mol Diagn. 2006;6(6):873-877. doi:10.1586/14737159.6.6.873
15. Ryberg D., Skaug V., Hewer A., et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 1997;18(7):1285-1289. doi:10.1093/carcin/18.7.1285
16. Glesse N., Rohr P., Monticielo O.A., et al. Genetic polymorphisms of glutathione S-transferases and cytochrome P450 enzymes as susceptibility factors to systemic lupus erythematosus in southern Brazilian patients. Mol Biol Rep. 2014;41(9):6167-6179. doi:10.1007/s11033-014-3496-8
17. Dourado D.F., Fernandes P.A., Ramos M.J. Mammalian cytosolic glutathione transferases. Curr Protein Pept Sci. 2008;9(4):325-337. doi:10.2174/138920308785132677
18. Kurashova N.A., Belyaeva E.V., Ershova O.A., et al. Assotsiatsiya polimorfizma genov GSTT1, GSTM1 s besplodiyem u muzhchin [Association of polymorphism of GSTT1 and GSTM1 genes with infertility in men]. Urologiya [Urologiia]. 2017;6:38-42. doi:10.18565/urology.2017.6.38-42 (In Russ.)
19. Kurashova N.A., Belyaeva E.V., Ershova O.A., et al. Assotsiatsiya polimorfnykh markerov gena GSTP1 s besplodiyem u muzhchin [The association of GSTP1 polymorphisms with male idiopathic infertility]. Urologiya [Urologiia]. 2019;2:50-54. doi:10.18565/urology.2019.2.50-54 (In Russ.)
20. Semenova N.V., Madaeva I.M., Bairova T.A., Kolesnikova L.I. Deletsionnyy polimorfizm GSTT1 i giperaktivatsiya protsessov lipoperoksidatsii pri insomnii klimaktericheskogo perioda [Deletion polymorphism of GSTT1 gene and lipid peroxidation hyperactivation in menopausal insomnia]. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova [The Korsakov’s Journal of Neurology and Psychiatry]. 2021;121(3):93-97. doi:10.17116/jnevro202112103193 (In Russ.)
21. Kassogue Y., Diakite B., Kassogue O., et al. Genetic polymorphism of drug metabolism enzymes (GSTM1, GSTT1 and GSTP1) in the healthy Malian population. Mol Biol Rep. 2020;47(1):393-400. doi:10.1007/s11033-019-05143-5
22. https://www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=11:67584718-67585718;v=rs1695;vdb=variation;vf=164390261#population_freq_AMR
23. Triska P., Chekanov N., Stepanov V., et al. Between Lake Baikal and the Baltic Sea: genomic history of the gateway to Europe. BMC Genet. 2017;18(Suppl 1):110. Published 2017 Dec 28. doi:10.1186/s12863-017-0578-3
24. Li J.Z., Absher D.M., Tang H., et al. Worldwide human relationships inferred from genome-wide patterns of variation. Science. 2008;319(5866):1100-1104. doi:10.1126/science.1153717
25. Sudmant P.H., Rausch T., Gardner E.J., et al. An integrated map of structural variation in 2,504 human genomes. Nature. 2015;526(7571):75-81. doi:10.1038/nature15394
26. Akbari M.R., Malekzadeh R., Shakeri R., et al. Candidate gene association study of esophageal squamous cell carcinoma in a high-risk region in Iran. Cancer Res. 2009;69(20):7994-8000. doi:10.1158/0008-5472.CAN-09-1149
27. Malik M.A., Upadhyay R., Mittal R.D., et al. Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors. Nutr Cancer. 2010;62(6):734-742. doi:10.1080/01635581003605904
28. Soya S.S., Padmaja N., Adithan C. Genetic polymorphisms of CYP2E1 and GSTP1 in a South Indian population--comparison with North Indians, Caucasians and Chinese [published correction appears in Asian Pac J Cancer Prev. 2006 Jul-Sep;7(3):502]. Asian Pac J Cancer Prev. 2005; 6(3): 315-319.
29. Nelis M., Esko T., Mägi R., et al. Genetic structure of Europeans: a view from the North-East [published correction appears in PLoS One. 2010; 5(3). doi: 10.1371/annotation/2849e182-aef5-4e2b-a5ac-0b74b30e5f48]. PLoS One. 2009;4(5):e5472. doi:10.1371/journal.pone.0005472
30. Yen-Revollo J.L., Van Booven D.J., Peters E.J., et al. Influence of ethnicity on pharmacogenetic variation in the Ghanaian population. Pharmacogenomics J. 2009;9(6):373-379. doi:10.1038/tpj.2009.28
31. Canto P., Canto-Cetina T., Juárez-Velázquez R., et al. Methylenetetrahydrofolate reductase C677T and glutathione S-transferase P1 A313G are associated with a reduced risk of preeclampsia in Maya-Mestizo women. Hypertens Res. 2008;31(5):1015-1019. doi:10.1291/hypres.31.1015
32. Kochetova O.V., Korytina G.F., Akhmadishina L.Z., et al. Analiz polimorfnykh lokusov genov fermentov antioksidantnoy zashchity v etnicheskikh gruppakh respubliki Bashkortostan [Analysis of polymorphic gene loci of antioxidant protection enzymes in three ethnic groups of the Republic of Bashkortostan]. Nauchnyye rezul’taty biomeditsinskikh issledovaniy [Research Results in Biomedicine]. 2019;5(2):22-33. (In Russ.). DOI: 10.18413/2658-6533-2019-5-2-0-3
33. https://www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=11:67585608-67586608;v=rs1138272;vdb=variation;vf=165303683
34. Belyaeva E.V., Yershova O.A. Polimorfizm gena glutation-s-transferazy klassa pi u podrostkov iz etnicheskoy gruppy buryat, prozhivayushchikh v Irkutskoy oblasti [Polymorphism of gene glutathion-s-transferase pi in teenagers from Buryat ethnic group living in the Irkutsk region]. Acta Biomedica Scientifica. 2016;1(5):165-169. (In Russ.) https://doi.org/10.12737/23418
35. Kurose K., Sugiyama E., Saito Y. Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development. Drug Metab Pharmacokinet. 2012;27(1):9-54. doi:10.2133/dmpk.dmpk-11-rv-111
36. Hamdy S.I., Hiratsuka M., Narahara K., et al. Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol. 2003;55(6):560-569. doi:10.1046/j.1365-2125.2003.01786.x
37. Agusa T., Iwata H., Fujihara J., et al. Genetic polymorphisms in glutathione S-transferase (GST) superfamily and arsenic metabolism in residents of the Red River Delta, Vietnam. Toxicol Appl Pharmacol. 2010;242(3):352-362. doi:10.1016/j.taap.2009.11.007
38. Rimando M.G., Chua M.N., Yuson Ed, et al. Prevalence of GSTT1, GSTM1 and NQO1 (609C>T) in Filipino children with ALL (acute lymphoblastic leukaemia). Biosci Rep. 2008;28(3):117-124. doi:10.1042/BSR20070010
39. Amtha R., Ching C.S., Zain R., et al. GSTM1, GSTT1 and CYP1A1 polymorphisms and risk of oral cancer: a case-control study in Jakarta, Indonesia. Asian Pac J Cancer Prev. 2009;10(1):21-26.
40. Lee E.J., Wong J.Y., Yeoh P.N., Gong N.H. Glutathione S transferase-theta (GSTT1) genetic polymorphism among Chinese, Malays and Indians in Singapore. Pharmacogenetics. 1995;5(5):332-334. doi:10.1097/00008571-199510000-00010
41. Ghosh T., Gupta S., Bajpai P., et al. Association of CYP1A1, GSTM1, and GSTT1 gene polymorphism with risk of oral submucous fibrosis in a section of North Indian population. Mol Biol Rep. 2012;39(10):9383-9389. doi:10.1007/s11033-012-1802-x
42. Saify K., Saadat I., Saadat M. Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and M1 (GSTM1) in selected populations of Afghanistan. Mol Biol Rep. 2012;39(8):7855-7859. doi:10.1007/s11033-012-1628-6
43. Shaikh R.S., Amir M., Masood A.I., et al. Frequency distribution of GSTM1 and GSTT1 null allele in Pakistani population and risk of disease incidence. Environ Toxicol Pharmacol. 2010;30(1):76-79. doi:10.1016/j.etap.2010.04.002
44. Bu H., Rosdahl I., Holmdahl-Källen K., et al. Significance of glutathione S-transferases M1, T1 and P1 polymorphisms in Swedish melanoma patients. Oncol Rep. 2007;17(4):859-864. doi:10.3892/or.17.4.859
45. Abbas A., Delvinquiere K., Lechevrel M., et al. GSTM1, GSTT1, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population: different pattern of squamous cell carcinoma and adenocarcinoma. World J Gastroenterol. 2004;10(23):3389-3393. doi:10.3748/wjg.v10.i23.3389
46. García-Closas M., Malats N., Silverman D., et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet. 2005;366(9486):649-659. doi:10.1016/S0140-6736(05)67137-1
47. Dialyna I.A., Miyakis S., Georgatou N., Spandidos D.A. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk. Oncol Rep. 2003;10(6):1829-1835.
48. Binková B., Smerhovský Z., Strejc P., et al. DNA-adducts and atherosclerosis: a study of accidental and sudden death males in the Czech Republic. Mutat Res. 2002;501(1-2):115-128. doi:10.1016/s0027-5107(02)00019-2
49. Toncheva D.I., Von Ahsen N., Atanasova S.Y., et al. Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy. J Nephrol. 2004;17(3):384-389.
50. Gajecka M., Rydzanicz M., Jaskula-Sztul R., et al. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res. 2005;574(1-2):112-123. doi:10.1016/j.mrfmmm.2005.01.027
51. Garte S., Gaspari L., Alexandrie A.K., et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2001;10(12):1239-1248.
52. Gra O., Mityaeva O., Berdichevets I., et al. Microarray-based detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 allele frequencies in native Russians. Genet Test Mol Biomarkers. 2010;14(3):329-342. doi:10.1089/gtmb.2009.0158
53. Hamdy S.I., Hiratsuka M., Narahara K., et al. Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol. 2003;55(6):560-569. doi:10.1046/j.1365-2125.2003.01786.x
54. Ebeshi B.U., Bolaji O.O., Masimirembwa C.M. Glutothione-S-transferase (M1 and T1) polymorphisms in Nigerian populations . J Med Genet Genomics. 2011;3(4):56–60.
55. Piacentini S., Polimanti R., Porreca F., Martínez-Labarga C., et al. GSTT1 and GSTM1 gene polymorphisms in European and African populations. Mol Biol Rep. 2011;38(2):1225-1230. doi:10.1007/s11033-010-0221-0
56. Buchard A., Sanchez J.J., Dalhoff K., Morling N. Multiplex PCR detection of GSTM1, GSTT1, and GSTP1 gene variants: simultaneously detecting GSTM1 and GSTT1 gene copy number and the allelic status of the GSTP1 Ile105Val genetic variant. J Mol Diagn. 2007;9(5):612-617. doi:10.2353/jmoldx.2007.070030
57. Dandara C., Sayi J., Masimirembwa C.M., et al. Genetic polymorphism of cytochrome P450 1A1 (Cyp1A1) and glutathione transferases (M1, T1 and P1) among Africans. Clin Chem Lab Med. 2002;40(9):952-957. doi:10.1515/CCLM.2002.167
58. Kasthurinaidu S.P., Ramasamy T., Ayyavoo J., et al. GST M1-T1 null allele frequency patterns in geographically assorted human populations: a phylogenetic approach. PLoS One. 2015;10(4):e0118660. Published 2015 Apr 13. doi:10.1371/journal.pone.0118660
59. Tabikhanova L.E., Osipova L.P., Voronina E.N., Filipenko M.L. Raspredeleniye polimorfnykh variantov genov biotransformatsii ksenobiotikov GSTM1, GSTT1 i GSTP1, v populyatsiyakh korennykh zhiteley i russkikh Vostochnoy Sibiri [Distribution of polymorphic variants of genes for xenobiotic biotransformation GSTM1, GSTT1 and GSTP1 in populations of native inhabitants and Russians of Eastern Siberia]. Meditsinskaya genetika [Medical Genetics]. 2019;18(2):24-34. (In Russ.) https://doi.org/10.25557/2073-7998.2019.02.24-34
60. Belyaeva E.V., Pervushina O.A. Polimorfizm genov glutation-stransferaz u detey raznykh etnicheskikh grupp [Glutation-stranspherase genes polymorphism in the different ethnic groups of children]. Acta Biomedica Scientifica. 2012;(3(1)):9-11. (In Russ.)
Review
For citations:
Belyaeva E.V., Bairova T.A., Ershova O.A., Sambyalova A.Yu., Paramonov A.I., Kurashova N.A., Dashiyev B.G., Kolesnikov S.I., Kolesnikova L.I. Genetic polymorphisms of xenobiotic detoxification system in the populations of Russians and Buryats. Medical Genetics. 2023;22(4):17-31. (In Russ.) https://doi.org/10.25557/2073-7998.2023.04.17-31